Marriage Counselors in Fairview Heights, IL Accepting Medicare

4 Marriage Counselors found. Showing 1 - 4

Mrs. Rachel Roe, MA,LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 8 Executive Dr Ste 200, Fairview Heights, IL 62208 Phone: 618-407-9578

Marie Clark, M.A., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 141 Market Pl, Suite 206, Fairview Heights, IL 62208 Phone: 314-644-1557    Fax: 314-453-4942

Donna E. Morgan, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 141 Market Pl, Suite 206, Fairview Heights, IL 62208 Phone: 618-398-7250    Fax: 618-398-6870

Marti Baricevic, LPC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 27 Marilyn Cir, Fairview Heights, IL 62208 Phone: 618-978-2812

News Archive

UTHealth scientists use new methods to explore naturally occurring 'knockout humans'

Researchers at The University of Texas Health Science Center at Houston are helping to make precision medicine a reality by sequencing entire exomes of people to assess chronic disease risk and drug efficacy. The results of a study on this topic were published in Nature Genetics on Monday.

Anti-diabetic drug alogliptin meets primary endpoint in EXAMINE trial

Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according to results of the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial presented at the European Society of Cardiology Congress.

Study finds that disarray in methylation helps tumors adapt to changing circumstances

The genetic tumult within cancerous tumors is more than matched by the disorder in one of the mechanisms for switching cells' genes on and off, scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard report in a new study.

FDA approves Codman's MEDSTREAM Programmable Infusion System

Codman & Shurtleff, Inc. (Codman), the global neurological device company, has received U.S. Food and Drug Administration (FDA) approval through a PMA supplement for its MEDSTREAM Programmable Infusion System, an implantable infusion pump and catheter system used in the treatment of spasticity, a movement disorder often caused by stroke, cerebral palsy, multiple sclerosis or spinal cord injury.

Bosutinib shows 'low' vascular, cardiac event risk profile

Third-generation tyrosine kinase inhibitor study findings suggest that bosutinib is associated with a low risk of vascular and cardiac events in patients undergoing first-line or subsequent treatment for chronic myeloid leukaemia.

Read more Medical News

› Verified 9 days ago